Background: Hypermetabolism is theorized in patients diagnosed with chronic kidney disease who are receiving maintenance hemodialysis (MHD). We aimed to distinguish key disease-specific determinants of resting energy expenditure to create a predictive energy equation that more precisely establishes energy needs with the intent of preventing protein-energy wasting. Materials and Methods: For this 3-year multisite cross-sectional study (N = 116), eligible participants were diagnosed with chronic kidney disease and were receiving MHD for at least 3 months. Predictors for the model included weight, sex, age, C-reactive protein (CRP), glycosylated hemoglobin, and serum creatinine. The outcome variable was measured resting energy expenditure (mREE). Regression modeling was used to generate predictive formulas and Bland-Altman analyses to evaluate accuracy. Results: The majority were male (60.3%), black (81.0%), and non-Hispanic (76.7%), and 23% were ࣙ65 years old. After screening for multicollinearity, the best predictive model of mREE (R 2 = 0.67) included weight, age, sex, and CRP. Two alternative models with acceptable predictability (R 2 = 0.66) were derived with glycosylated hemoglobin or serum creatinine. Based on BlandAltman analyses, the maintenance hemodialysis equation that included CRP had the best precision, with the highest proportion of participants' predicted energy expenditure classified as accurate (61.2%) and with the lowest number of individuals with underestimation or overestimation. Conclusions: This study confirms disease-specific factors as key determinants of mREE in patients on MHD and provides a preliminary predictive energy equation. Further prospective research is necessary to test the reliability and validity of this equation across diverse populations of patients who are receiving MHD. (JPEN J Parenter Enteral Nutr. 2018;42:587-596) 
Introduction
In the United States, 1 out of 2 patients diagnosed with chronic kidney disease (CKD) who are receiving maintenance dialysis will die within 3 years of initiating renal replacement therapy, translating to a life expectancy that is less than one-third that of the general population. 1 This is an important problem, given the nearly 700,000 individuals in the United States who are affected, the high cost in human suffering and loss, and the expense to Medicare and private insurance. Causes for this high mortality rate are multifactorial and interdependent. Protein-energy malnutrition or wasting is 1 independent risk factor for mortality. [2] [3] [4] [5] [6] [7] [8] [9] Disease progression leads to a decline in appetite and oral intake, as well as physiologic alterations in nutrient and energy metabolism. 8, [10] [11] [12] [13] [14] To offset the consequent sequelae of the disease process, nutrition care must be optimized. Effective nutrition intervention requires an appropriate predictive energy equation based on an understanding of clinical factors and mechanisms and an accurate determination of energy expenditure. Resting energy expenditure (REE), the largest component of the total energy expenditure, 15 is most accurately measured in acute and chronic illness by indirect calorimetry (IC) utilizing a metabolic cart. 16 Although measuring energy expenditure with IC is the preferred method in CKD, it is not routinely done in this practice setting, 17 because the methods required are cumbersome and the equipment used is cost-prohibitive. 18, 19 Typically, REE is estimated from a predictive formula that has been validated in other disease states or patient populations 20, 21 and then extrapolated to CKD, with serious limitations. 22 Despite the >200 predictive energy equations currently published, 18, 19, 23 a "best practice" formula does not exist for CKD. 24 An initial investigation 25 has derived a disease-specific equation, but it used heterogeneous treatment groups and a small sample (N = 20) for validation.
As kidney disease progresses to end-stage renal failure, there are substantive alterations in energy expenditure that have not been clearly elucidated, and when coupled with a simultaneous decline in dietary intake, an energy imbalance is engendered. 3, 5, [10] [11] [12] 14, 26, 27 This discordance will eventually result in a suboptimal nutrition status and place the individual at an increased risk for morbidity and mortality. To further our understanding of energy expenditure in CKD, we hypothesized that there were several clinical factors that influence energy requirements. 24, [28] [29] [30] [31] [32] We recently published a preliminary predictive model that is disease specific with better precision than some of the common formulas utilized, but we were not able to fully validate it for clinical use. 33 Subsequently, in a larger sample, we were able to measure REE and identify key clinical factors similar to our pilot work. In addition, we were able to better refine and internally validate our predictive energy equation for patients diagnosed with stage 5 CKD who are receiving maintenance hemodialysis (MHD).
Methods

Participants
Participants who were treated by MHD were recruited from outpatient clinics associated with study teams from Rutgers University, Case Western Reserve University, and Pennsylvania State University-Hershey Medical Center. The detailed study protocol-comprising inclusion and exclusion criteria as well as the training calibration completed at the study sites-has been published elsewhere. 34 Informed consent, which followed Institutional Review Board requirements at each research site (Case Western Reserve University 08-12-37, Pennsylvania State UniversityHershey Medical Center 40781EP, and Rutgers University 2012001976), was obtained from those willing to participate and who met eligibility criteria.
Study Measurements
Each participant had testing completed on a nonhemodialysis treatment day at the designated research sites. Participants were instructed to fast 12 hours prior to the research appointment, but if not medically feasible, a 4-hour fast was deemed acceptable.
Measured REE
Energy expenditure was measured by IC with the Quark RMR (Cosmed, Rome, Italy) at Rutgers University and the Pennsylvania State University-Hershey Medical Center and by the Vmax Encore metabolic cart (CareFusion, Yorba Linda, CA) at Case Western Reserve University. For the purposes of this study, the Quark RMR (newer IC device) was validated against the criterion standard, Deltatrac Metabolic Monitor (Sensormedics, Yorba Linda, CA), and was found to be of suitable precision for measuring REE. 21 The Vmax Encore and the Quark RMR were also tested for reliability and were found to be comparable devices. 35 Additional details of the reliability testing completed have been reported. 34 The IC measurements were completed in accordance to evidence-based practice guidelines 18 and were instituted and followed at each research institution to minimize measurement error. 35 The 5-minute steady-state protocol followed the methodology published by Olejnik et al. 34 To 
Laboratory Assays
Blood samples were drawn at each clinical site after all other clinical measurements were obtained on a nonhemodialysis treatment day or immediately predialysis. When blood could not be drawn, respective values were abstracted from the medical record for their most recent predialysis monthly chemistries. Timing of the blood draw (nonhemodialysis vs predialysis) was tested for equivalence in high-sensitivity C-reactive protein (CRP; P = .985) and serum creatinine (SCr; P = .095). Following centrifugation, serum for blood urea nitrogen, SCr, albumin, and CRP and plasma for intact parathyroid hormone (iPTH) were obtained, aliquoted, and frozen at −80°C. Whole blood was aliquoted and frozen for glycosylated hemoglobin (A1c 
Missing Values and Data for Analyses
The analysis plan called for randomly splitting the data set into a model creation subsample and a model validation subsample. While the initial recruitment plan had assumed some amount of missing data, the final number of subjects with complete data was lower than anticipated (n = 95). The original power analysis had called for n = 60 to generate the initial equation and n = 95 for the validation component. We determined that even after imputation (n = 116), splitting the data set risked overfitting, and so we decided to analyze the entire sample.
To maximize data available for analyses, missing values were imputed. We first determined that missing values were not monotonic 37 and were not related to measures of patient disease burden. Multivariate normal (MVN) imputation was completed with Stata 14 with 50 replications. 38 Although values on the predictor variables were imputed per a range of demographic, clinical, and laboratory variables, a solution had to be forced due to missing values on the nonimputed variables. This decreased our confidence in the reliability of the imputed values. We then imputed values with multiple regression. Because imputation by multiple regression can reduce variance, 39 we ran a sample multivariate model predicting mREE to compare coefficients and standard errors on 3 samples: subjects with complete data (n = 95), subjects with missing values imputed via MVN imputation (n = 109), and subjects with values imputed via multiple regression (with the same nonimputed variables as were used in the MVN imputation but with pairwise deletion to retain as much information as possible; n = 120). We then compared coefficients and standard errors of the 3 models (see supplemental material and Table S1 ) to determine whether there were any serious discrepancies among parameters for the different models. Standard errors in the regression imputed model did not vary by >6% from either the MVN imputation or complete data models; hence, values from the multivariate regression imputed model were used. Because of device malfunction on 1 day of study, 4 cases had to be removed, leaving a final sample of 116 participants. The demographic and clinical characteristics of the 4 cases removed were similar to the larger sample.
Development of Predictive Models
The general procedure for developing the predictive model was described by Byham-Gray et al. 33 Briefly, a list of potential predictors was developed according to prior research. 28, 30, 40 Variables were then screened for bivariate linear relationships with 5-minute mREE measures, and those with a correlation value of P < .15 were identified as potential predictors. Bivariate relationships among the selected predictors were then examined, and when they were highly correlated (r ࣙ 0.7), the potential predictor with the strongest relationship to mREE was selected. All continuous variables identified as potential predictors at this stage were then screened for quadratic relationships with mREE via a curve-fitting procedure. Linear and quadratic models were compared to determine whether the quadratic model provided a substantial improvement over the linear model. Multiple regression was used to evaluate the contribution of the potential predictors from the above procedure. All final models were assessed for collinearity, functional form, normality of errors, and homoscedasticity.
Evaluation of Accuracy of the Predictive Models
Bland-Altman analyses 41 were used to evaluate the accuracy of the predicted REE values relative to mREE. Mean model bias and 95% CI around mean bias of each model were computed. Standard errors of the 3 bias estimates were computed, and accuracy of the bias estimates is reported.
Results
A total of 116 participants were available for analysis ( Figure 1 ). The majority were male (60.3%, n = 70), black (81.0%, n = 94), and non-Hispanic (76.7%, n = 89; Table 1 ). The mean age of participants was 56.32 ± 11.92 years, with 23.3% (n = 27) at least 65 years old. Hypertension (40.5%, n = 47) and diabetes (37.1%, n = 43) were the 2 leading etiologies of kidney disease reported. The average dialysis vintage was >5 years (61.64 ± 69.93 months). The mean weight was 87.01 ± 20.17 kg, and the mean body mass index (BMI) was 30.37 ± 6.63. Average CRP values were >10 mg/dL, and serum albumin levels were within normal limits (4.18 ± 0.44 g/dL). iPTH ranged from as low as 10.90 to as high as 4315.00 pg/mL. Mean A1c values were <7.0%.
Average mREE was 1522.59 ± 334.92 kcal. The distribution of mREE was slightly skewed in the sample, due largely to the presence of 4 outliers that were confirmed to be accurate. Transforming the outcome variable would dramatically decrease the clinical utility of the final equation, and with no clinical justification for dropping these cases, such outliers were retained in the model. 
Results of Models to Predict mREE
Following the above procedure, in addition to 1 anthropometric measure (eg, weight), age, sex (coded 0 = female, 1 = male), and CRP levels were identified as the strongest predictors of mREE (Table 2 ). A1c and SCr were the nextstrongest predictors of mREE. All potential predictors were evaluated for nonlinear relationships with mREE. None of the quadratic relationships between the above variables and mREE improved model fit by >3%. In the interest of creating models that would be accurate as well as useful for clinicians, no quadratic terms were included in the models.
Because a particular laboratory value may not be available in every clinical situation, 3 models were constructeddiffering according to the laboratory value included in the base model (CRP, A1c, or SCr). All models significantly predicted mREE (P < .001; Table 3 ). The model including both weight and CRP had the highest proportion of variance explained (R 2 = 0.67), with the models including weight and SCr or A1c being equivalent (R 2 = 0.66). where age = years, postdialysis weight = kg, and SCr (mg/dL).
MHD Equation (MHDE)-CRP.
Evaluation of REE Equations
While none of the models demonstrated statistically significant bias in predicted REE (kcal/d) relative to mREE (all P > .05), the model that included A1c showed a slight mean underestimate (-77.35 ± 184.79) of mREE (Table 4 , Figure 2 ). Models with CRP and SCr had a mean bias of zero. The 95% confidence intervals of the mean bias were all approximately equal. When ±10% of REE (±152) is used as a threshold for accuracy, the model with CRP had the highest proportion of subjects classified as accurate (61.2%, n = 71), with both A1c and SCr models classifying 56.9% accurately.
Discussion
In comparison with healthy controls, the energy expenditure of individuals receiving MHD is significantly higher, placing them at greater risk for hypercatabolism and, therefore, protein-energy wasting. 11, 30, 42, 43 To minimize such risk, research efforts aimed at more fully understanding the contributors of energy expenditure are critical. On the basis of our findings, we continue to support the hypothesis that the addition of laboratory data produces betterfitting models of mREE among patients receiving MHD than with demographic and anthropometric characteristics alone, as is commonly done in predictive formulas for healthy populations. 44, 45 Hence, we were able to explain a greater proportion of the variance in mREE among patients diagnosed with CKD, with a higher degree of precision than any of the other earlier investigations. 25, 33 In so doing, we confirmed similar predictors of mREE from our pilot study and were able to create and internally validate a model within a larger sample of patients receiving MHD.
As is evident in the research literature of non-CKD and CKD samples, demographic and anthropometric characteristics are predictors of mREE. 19, [44] [45] [46] Since the primary goal of our research is to create a predictive model of REE that can be easily used in clinical practice, we chose weight as the main anthropometric parameter, as it is routinely collected within the dialysis clinic. While bioelectrical impedance analysis data and/or fat-free mass estimates derived from these data can be applied, we did not include them within our procedures for developing a model with the greatest clinical utility and hence replicated our earlier methodology. 34 Thus, in our sample, weight remained the strongest predictor of mREE and therefore is a reasonable estimate for metabolically active tissue or fat-free mass. 47 Since a large proportion of the sample had BMI ࣙ30, it would be instructive in a future investigation with a larger robust data set to stratify by BMI category to determine whether adiposity provides any additional explanation for mREE. Nonetheless, weight was the anthropometric measure chosen for the predictive models constructed in this study based on its superior clinical utility. As expected, age and sex were contributors of mREE, which is congruent with general populations. 44, 45 Factors that are proposed to influence energy expenditure beyond the traditional ones and are specific to CKD include parathyroid hormone concentrations, inflammation, and the presence of diabetes. 30, 31, 48 In 2 separate studies, inflammation was associated with an acceleration in energy expenditure among CKD patients. 40, 48 Similar to our preliminary findings, 33 this sample of patients receiving MHD were largely inflamed, and the CRP levels remained a strong predictor of mREE. As such, our results suggest that the REE among these patients is elevated and that any of the existing predictive energy equations that do not account for these factors could grossly underestimate energy determinations with potentially harmful side effects. Of the 3 laboratory values examined in this analysis, CRP most improved the fit of the model.
In studying the effects of comorbid conditions on energy expenditure, Pupim and associates 28 reported that the unadjusted mREE in patients with diabetes was significantly higher than in patients without disease. Theorizing that hyperglycemia may be a significant contributor to energy expenditure in CKD, we included A1c as a parameter within our study. Thus, we replaced CRP (which may not be routinely collected within a dialysis facility) with A1c to examine how it would perform in our predictive model. The presence of diabetes did assist in explaining the variance in the mREE. However, A1c may have been a stronger predictor if there were a larger proportion of participants with levels >7%. Further study into the relationship between glycemia and energy expenditure is warranted.
SCr may reflect muscle mass in healthy groups. Since creatinine is excreted by the kidney, it is an imprecise surrogate marker in CKD. Nonetheless, serial monitoring and tailored acceptable limits of SCr in stage 5 CKD may provide additional insight into the body habitus. 3, 49 Because SCr values are routinely collected for the purpose of determining dialytic adequacy and protein nutriture, we chose to evaluate its ability to predict mREE in this sample. In our predictive modeling, SCr continues to be an alternate parameter that may be used when either CRP or A1c is unavailable or missing. 33 SCr is convenient and easily accessible, and its inclusion improved the practicality of the predictive model. Therefore, data once again support the need to have CKD-specific parameters when trying to explain mREE in this population.
Moderate to severe secondary hyperparathyroidism has been reported as 1 of the strongest determinants of mREE in a multivariate linear regression analysis. 30 Conversely, iPTH levels were not a significant contributor for mREE in our sample. While our results may seem counterintuitive, the findings are likely more related to the use of imputed values for the missing data. In light of the metabolic compromise exhibited during hyperparathyroidism, we continue to hypothesize that elevated iPTH levels are expected to be a contributor to the overall disease state and should be accounted for in the overall explanation for energy expenditure. Hence, this disease-specific parameter merits further scientific inquiry.
In terms of its overall precision, our equation explains more of the variance of mREE than our earlier model in a similar MHD population. 33 We also gained a higher proportion of participants for whom the equation "accurately" estimated REE, which is higher than other commonly reported equations, even in general populations. 33, 45, 46 Nonetheless, there are individuals who fell outside the band of acceptability, and additional exploration into improving the bias is warranted and limits the broad application of such findings without further inquiry. A larger diverse data set and a more comprehensive analysis of the characteristics among individuals for which the model may not "fit" will afford a greater understanding of energy expenditure in CKD. Also, there still remains approximately 40% of the variance of the mREE that has not been explained by current models. As such, there are other factors existing in patients receiving MHD that have not yet been identified. Hence, completing future investigations focused on these innovative approaches would potentially lead to a more tailored mechanism for determining REE in this unique population and thereby support precision medicine.
While traditional IC measurement remains impractical for most clinical settings and the need for more precise modeling of energy expenditure is still of considerable research interest, a new generation of IC devices, as described by the International Multicentric Study Group for Indirect Calorimetry, 50 may prove to be easier, less expensive, and potentially useful within a myriad of inpatient and outpatient areas. Future research may determine whether these newer versions offer better clinical utility than either traditional IC devices or disease-specific predictive energy equations.
In conclusion, this study confirms disease-specific factors as key determinants of mREE in patients receiving MHD and provides a preliminary predictive energy equation. Further prospective research is necessary to test the reliability and validity of this equation across diverse populations of patients receiving MHD. Despite our findings, a few limitations motivate us to be cautious in the interpretation of the results. We limited generalizability due to the rather homogeneous sample of patient demographics and disease acuity (eg, mostly stable patients receiving MHD). While more clinically useful, the use of weight instead of fatfree mass derived from bioelectrical impedance analysis data may have inherent errors, and future research should integrate such data with more sophisticated analytic techniques. Last, the use of multiple imputations for missing data may represent a conservative estimate of potential predictors in the regression modeling conducted and may mask the contribution of other factors that determine energy expenditure.
